BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36322612)

  • 1. Supercritical CO
    Sadeghi F; Kamali H; Kouhestanian S; Hadizadeh F; Nokhodchi A; Afrasiabi Garekani H
    Pharm Dev Technol; 2022 Dec; 27(10):999-1008. PubMed ID: 36322612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of high pressure homogenization on physicochemical properties of curcumin nanoparticles prepared by antisolvent crystallization using HPMC or PVP.
    Homayouni A; Sohrabi M; Amini M; Varshosaz J; Nokhodchi A
    Mater Sci Eng C Mater Biol Appl; 2019 May; 98():185-196. PubMed ID: 30813018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the dissolution properties of curcumin using dense gas antisolvent technology.
    Kurniawansyah F; Quachie L; Mammucari R; Foster NR
    Int J Pharm; 2017 Apr; 521(1-2):239-248. PubMed ID: 28185959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality by Design-Based Crystallization of Curcumin Using Liquid Antisolvent Precipitation: Micromeritic, Biopharmaceutical, and Stability Aspects.
    Som S; Singh SK; Khatik GL; Kapoor B; Gulati M; Kuppusamy G; Anandhakrishnan NK; Kumar B; Yadav AK; Kumar R; Singh PK; Khursheed R; Kumar R; Pandey NK; Jyoti J; Mohanta S; Porwal O
    Assay Drug Dev Technol; 2020 Jan; 18(1):11-33. PubMed ID: 31268345
    [No Abstract]   [Full Text] [Related]  

  • 6. Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization.
    Homayouni A; Amini M; Sohrabi M; Varshosaz J; Nokhodchi A
    Int J Pharm; 2019 May; 562():124-134. PubMed ID: 30898640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of apigenin nanoparticles using antisolvent crystallization technology: A comparison of supercritical antisolvent, ultrasonic-assisted liquid antisolvent, and high-pressure homogenization technologies.
    Yan T; Wang H; Song X; Yan T; Ding Y; Luo K; Zhen J; He G; Nian L; Wang S; Wang Z
    Int J Pharm; 2022 Aug; 624():121981. PubMed ID: 35792228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of curcumin solid dispersion using HPMC.
    Yu JY; Kim JA; Joung HJ; Ko JA; Park HJ
    J Food Sci; 2020 Nov; 85(11):3866-3873. PubMed ID: 33067846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.
    Homayouni A; Sadeghi F; Varshosaz J; Afrasiabi Garekani H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2014 Oct; 122():591-600. PubMed ID: 25124835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process.
    Park HJ; Kim MS; Lee S; Kim JS; Woo JS; Park JS; Hwang SJ
    Int J Pharm; 2007 Jan; 328(2):152-60. PubMed ID: 16959448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation of curcumin-EC sustained-release composite particles by supercritical CO2 anti-solvent technology].
    Bai WL; Yan TY; Wang ZX; Huang DC; Yan TX; Li P
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):226-30. PubMed ID: 26080549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.
    Zhang X; Zhao X; Zu Y; Chen X; Lu Q; Ma Y; Yang L
    Int J Mol Sci; 2012 Oct; 13(10):12598-607. PubMed ID: 23202916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
    Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
    Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
    Gandhi AV; Thipsay P; Kirthivasan B; Squillante E
    AAPS PharmSciTech; 2017 Nov; 18(8):3140-3150. PubMed ID: 28534299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategy of nitrofurantoin: co-crystal or solid dispersion?
    Teoh XY; Bt Mahyuddin FN; Ahmad W; Chan SY
    Pharm Dev Technol; 2020 Feb; 25(2):245-251. PubMed ID: 31690150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.